vs
Andersons, Inc.（ANDE）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是Andersons, Inc.的1.8倍（$585.5M vs $329.5M），Andersons, Inc.净利率更高（20.5% vs -6.9%，领先27.3%），科睿唯安同比增速更快（-1.4% vs -2.4%），科睿唯安自由现金流更多（$78.9M vs $-77.1M），过去两年Andersons, Inc.的营收复合增速更高（-1.8% vs -5.1%）
安德森公司（The Andersons, Inc.）是1947年成立的美国农业企业，总部位于俄亥俄州莫米。公司起源于1940年代服务粮食行业的安德森货运站，是深耕农业领域的多元化企业，业务覆盖大宗商品贸易、可再生能源以及植物营养板块。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
ANDE vs CLVT — 直观对比
营收规模更大
CLVT
是对方的1.8倍
$329.5M
营收增速更快
CLVT
高出1.0%
-2.4%
净利率更高
ANDE
高出27.3%
-6.9%
自由现金流更多
CLVT
多$156.0M
$-77.1M
两年增速更快
ANDE
近两年复合增速
-5.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $329.5M | $585.5M |
| 净利润 | $67.4M | $-40.2M |
| 毛利率 | 70.3% | 67.2% |
| 营业利润率 | 26.6% | — |
| 净利率 | 20.5% | -6.9% |
| 营收同比 | -2.4% | -1.4% |
| 净利润同比 | 49.6% | -163.1% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANDECLVT
| Q1 26 | — | $585.5M | ||
| Q4 25 | $329.5M | $617.0M | ||
| Q3 25 | $295.8M | $623.1M | ||
| Q2 25 | $535.0M | $621.4M | ||
| Q1 25 | $370.8M | $593.7M | ||
| Q4 24 | $337.5M | $663.0M | ||
| Q3 24 | $231.9M | $622.2M | ||
| Q2 24 | $492.5M | $650.3M |
净利润ANDECLVT
| Q1 26 | — | $-40.2M | ||
| Q4 25 | $67.4M | $3.1M | ||
| Q3 25 | $20.1M | $-28.3M | ||
| Q2 25 | $7.9M | $-72.0M | ||
| Q1 25 | $284.0K | $-103.9M | ||
| Q4 24 | $45.1M | $-191.8M | ||
| Q3 24 | $27.4M | $-65.6M | ||
| Q2 24 | $36.0M | $-304.3M |
毛利率ANDECLVT
| Q1 26 | — | 67.2% | ||
| Q4 25 | 70.3% | 66.8% | ||
| Q3 25 | 57.8% | 65.0% | ||
| Q2 25 | 29.6% | 67.2% | ||
| Q1 25 | 41.2% | 65.1% | ||
| Q4 24 | 63.1% | 65.7% | ||
| Q3 24 | 76.4% | 66.2% | ||
| Q2 24 | 35.6% | 67.2% |
营业利润率ANDECLVT
| Q1 26 | — | — | ||
| Q4 25 | 26.6% | 6.7% | ||
| Q3 25 | 8.7% | 7.1% | ||
| Q2 25 | 4.6% | 1.1% | ||
| Q1 25 | 0.9% | -3.5% | ||
| Q4 24 | 19.9% | -9.4% | ||
| Q3 24 | 26.8% | 3.5% | ||
| Q2 24 | 11.6% | -36.9% |
净利率ANDECLVT
| Q1 26 | — | -6.9% | ||
| Q4 25 | 20.5% | 0.5% | ||
| Q3 25 | 6.8% | -4.5% | ||
| Q2 25 | 1.5% | -11.6% | ||
| Q1 25 | 0.1% | -17.5% | ||
| Q4 24 | 13.4% | -28.9% | ||
| Q3 24 | 11.8% | -10.5% | ||
| Q2 24 | 7.3% | -46.8% |
每股收益（稀释后）ANDECLVT
| Q1 26 | — | $-0.06 | ||
| Q4 25 | — | $0.00 | ||
| Q3 25 | $0.59 | $-0.04 | ||
| Q2 25 | $0.23 | $-0.11 | ||
| Q1 25 | $0.01 | $-0.15 | ||
| Q4 24 | $1.31 | $-0.27 | ||
| Q3 24 | $0.80 | $-0.09 | ||
| Q2 24 | $1.05 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | — |
| 总债务越低越好 | $560.0M | $4.3B |
| 股东权益账面价值 | $1.2B | $4.8B |
| 总资产 | $3.7B | $10.9B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ANDECLVT
| Q1 26 | — | — | ||
| Q4 25 | $98.3M | $329.2M | ||
| Q3 25 | — | $318.7M | ||
| Q2 25 | — | $362.6M | ||
| Q1 25 | — | $354.0M | ||
| Q4 24 | $561.8M | $295.2M | ||
| Q3 24 | — | $388.5M | ||
| Q2 24 | — | $376.4M |
总债务ANDECLVT
| Q1 26 | — | $4.3B | ||
| Q4 25 | $560.0M | $4.3B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | $608.2M | $4.5B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $4.6B |
股东权益ANDECLVT
| Q1 26 | — | $4.8B | ||
| Q4 25 | $1.2B | $4.8B | ||
| Q3 25 | $1.2B | $4.9B | ||
| Q2 25 | $1.4B | $5.0B | ||
| Q1 25 | $1.4B | $5.0B | ||
| Q4 24 | $1.4B | $5.1B | ||
| Q3 24 | $1.3B | $5.5B | ||
| Q2 24 | $1.3B | $5.6B |
总资产ANDECLVT
| Q1 26 | — | $10.9B | ||
| Q4 25 | $3.7B | $11.1B | ||
| Q3 25 | $3.3B | $11.2B | ||
| Q2 25 | $3.4B | $11.4B | ||
| Q1 25 | $3.8B | $11.5B | ||
| Q4 24 | $4.1B | $11.5B | ||
| Q3 24 | $3.4B | $12.0B | ||
| Q2 24 | $3.3B | $12.1B |
负债/权益比ANDECLVT
| Q1 26 | — | 0.89× | ||
| Q4 25 | 0.45× | 0.89× | ||
| Q3 25 | — | 0.90× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 0.45× | 0.88× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $134.7M |
| 自由现金流经营现金流 - 资本支出 | $-77.1M | $78.9M |
| 自由现金流率自由现金流/营收 | -23.4% | 13.5% |
| 资本支出强度资本支出/营收 | 21.5% | 9.5% |
| 现金转化率经营现金流/净利润 | -0.09× | — |
| 过去12个月自由现金流最近4个季度 | $-56.1M | $333.9M |
8季度趋势，按日历期对齐
经营现金流ANDECLVT
| Q1 26 | — | $134.7M | ||
| Q4 25 | $-6.2M | $159.9M | ||
| Q3 25 | $233.9M | $181.1M | ||
| Q2 25 | $299.3M | $116.3M | ||
| Q1 25 | $-350.0M | $171.2M | ||
| Q4 24 | $268.8M | $141.3M | ||
| Q3 24 | $-2.1M | $202.9M | ||
| Q2 24 | $304.4M | $126.2M |
自由现金流ANDECLVT
| Q1 26 | — | $78.9M | ||
| Q4 25 | $-77.1M | $89.2M | ||
| Q3 25 | $167.0M | $115.5M | ||
| Q2 25 | $250.5M | $50.3M | ||
| Q1 25 | $-396.6M | $110.3M | ||
| Q4 24 | $212.9M | $59.1M | ||
| Q3 24 | $-40.0M | $126.3M | ||
| Q2 24 | $275.8M | $60.3M |
自由现金流率ANDECLVT
| Q1 26 | — | 13.5% | ||
| Q4 25 | -23.4% | 14.5% | ||
| Q3 25 | 56.5% | 18.5% | ||
| Q2 25 | 46.8% | 8.1% | ||
| Q1 25 | -106.9% | 18.6% | ||
| Q4 24 | 63.1% | 8.9% | ||
| Q3 24 | -17.2% | 20.3% | ||
| Q2 24 | 56.0% | 9.3% |
资本支出强度ANDECLVT
| Q1 26 | — | 9.5% | ||
| Q4 25 | 21.5% | 11.5% | ||
| Q3 25 | 22.6% | 10.5% | ||
| Q2 25 | 9.1% | 10.6% | ||
| Q1 25 | 12.6% | 10.3% | ||
| Q4 24 | 16.6% | 12.4% | ||
| Q3 24 | 16.3% | 12.3% | ||
| Q2 24 | 5.8% | 10.1% |
现金转化率ANDECLVT
| Q1 26 | — | — | ||
| Q4 25 | -0.09× | 51.58× | ||
| Q3 25 | 11.61× | — | ||
| Q2 25 | 38.10× | — | ||
| Q1 25 | -1232.46× | — | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | — | ||
| Q2 24 | 8.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
